Attitudes and practices regarding use of progesterone to prevent preterm births

American Journal of Perinatology

Volumn 26, Issue 7, 2009, Pages 529-536

  Henderson, Zsakeba T ^a   Power, Michael L ^b   Berghella, Vincenzo ^c   Lackritz, Eve M ^a   Schulkin, Jay ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b INTER AMERICAN DEVELOPMENT BANK   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Attitudes and practices; Preterm birth; Prevention; Progesterone

Indexed keywords

PROGESTERONE;

ADULT; AGED; ARTICLE; ATTITUDE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL PROTOCOL; DEMOGRAPHY; FEMALE; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; OBSTETRIC CARE; PARTHENOGENESIS; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SPONTANEOUS PLACENTAL DELIVERY; ULTRASOUND; UTERINE CERVIX DILATATION;

ATTITUDE OF HEALTH PERSONNEL; FEMALE; HEALTH CARE SURVEYS; HUMANS; INFANT, NEWBORN; INJECTIONS, INTRAMUSCULAR; MALE; OBSTETRICS; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; PROBABILITY; PROGESTERONE; QUESTIONNAIRES; RISK ASSESSMENT;

EID: 67749116542     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0029-1215432     Document Type: Article

References (23)

1. Hamilton BE, Minino AM, Martin JA, Kochanek KD, Strobino DM, Guyer B. Annual summary of vital statistics: 2005. Pediatrics 2007;119:345-360
2. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003;188:419-424
3. Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379-2385 (Pubitemid 36682816)
4. American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Use of progesterone to reduce preterm birth. Obstet Gynecol 2003;102:1115-1116
5. Norwitz ER, Bahtiyar MO, Sibai BM. Defining standards of care in maternal-fetal medicine. Am J Obstet Gynecol 2004;191:1491-1496
6. Ness A, Baxter J, Hyslop T, Berghella V. Progesterone for preventing premature birth: practice patterns of board-certified maternal-fetal medicine specialists in the United States. J Reprod Med 2006;51:411-415 (Pubitemid 43765084)
7. Ness A, Dias T, Damus K, Burd I, Berghella V. Impact of the recent randomized trials on the use of progesterone to prevent preterm birth: a 2005 follow-up survey. Am J Obstet Gynecol 2006;195:1174-1179
8. Coleman VH, Power ML, Zinberg S, Schulkin J. Contemporary clinical issues in outpatient obstetrics and gynecology: findings of the Collaborative Ambulatory Research Network, 2001-2004: part II. Obstet Gynecol Surv 2004;59:787-794
9. Coleman VH, Power ML, Zinberg S, Schulkin J. Contemporary clinical issues in outpatient obstetrics and gynecology: findings of the Collaborative Ambulatory Research Network, 2001-2004: part I. Obstet Gynecol Surv 2004;59:780-786
10. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007;357:462-469 (Pubitemid 47204875)
11. Gulmezoglu AM, Langer A, Piaggio G, Lumbiganon P, Villar J, Grimshaw J. Cluster randomised trial of an active, multifaceted educational intervention based on the WHO Reproductive Health Library to improve obstetric practices. BJOG 2007;114:16-23 (Pubitemid 44923927)
12. Parer JT. Obstetric technologies: what determines clinical acceptance or rejection of results of randomized controlled trials? Am J Obstet Gynecol 2003;188:1622-1625
13. Thorp J. Evidence-based medicine - where is your effectiveness? BJOG 2007;114:1-2
14. Kellerman SE, Herold J. Physician response to surveys. A review of the literature. Am J Prev Med 2001;20:61-67 (Pubitemid 32013069)
15. Power ML, Cogswell ME, Schulkin J. Obesity prevention and treatment practices of U.S. obstetrician-gynecologists. Obstet Gynecol 2006;108:961-968 (Pubitemid 44498259)
16. Dodd JM, Ashwood P, Flenady V, Jenkins-Manning S, Cincotta R, Crowther CA. A survey of clinician and patient attitudes towards the use of progesterone for women at risk of preterm birth. Aust N Z J Obstet Gynaecol 2007;47:106-109 (Pubitemid 46390185)
17. Northen AT, Norman GS, Anderson K, et al. Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo. Obstet Gynecol 2007;110:865-872 (Pubitemid 47508752)
18. Thornton JG. Progesterone and preterm labor - still no definite answers. N Engl J Med 2007;357:499-501
19. O'Brien JM, Adair CD, Lewis DF, et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007;30:687-696
20. Rouse DJ, Caritis SN, Peaceman AM, et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007;357:454-461 (Pubitemid 47204874)
21. Dodd JM, Flenady VJ, Cincotta R, et al. Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol 2008;112:127-134
22. Thornton JG. Supplement to: progesterone and preterm labor - still no definite answers. N Engl J Med 2007;357:499-501
23. American College of Obstetricians and Gynecology. ACOG Committee Opinion number 419. Use of progesterone to reduce preterm birth. Obstet Gynecol 2008;112:963-965